Strata Critical Medical Income Statement (2019-2026) | SRTA

Income Statement Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Revenue & cost
Revenue (Quarter)
42.54M26.63M62.26M45.27M60.99M71.44M47.48M51.51M67.94M36.06M36.39M35.95M70.80M49.30M66.79M67.38M72.51M
Cost of Revenue (Quarter)
33.63M23.71M54.23M38.11M50.62M55.86M38.47M41.38M51.59M28.55M31.37M28.89M53.06M37.68M55.12M53.27M57.29M
Gross Profit (Quarter)
8.91M2.92M8.03M7.16M10.37M15.58M9.01M10.14M16.35M7.51M5.01M7.05M17.74M11.61M11.67M14.12M15.21M
Operating items
Amortization - Intangibles (Quarter)
0.41M1.49M6.63M
Research & Development (Quarter)
1.46M1.80M1.90M1.12M1.44M2.69M-3.40M0.67M2.40M0.31M6.92M1.44M1.63M0.45M
Selling, General & Administrative (Quarter)
26.75M13.98M26.12M16.26M18.41M19.27M41.24M17.21M25.14M13.87M11.72M12.33M20.14M16.30M17.92M15.61M14.00M
Other Operating Expenses (Quarter)
36.06M-24.47M17.35M40.72M53.35M56.94M45.27M43.50M52.56M28.97M-93.57M-1.03M53.98M38.17M-100.74M1.49M6.63M
Operating Expenses (Quarter)
64.27M-8.70M45.37M58.10M73.20M78.89M83.11M61.38M80.09M43.15M-74.94M12.74M75.75M54.92M-82.82M17.09M20.62M
Operating Income (Quarter)
-21.73M-13.69M-23.42M-12.83M-12.21M-7.45M-35.63M-9.87M-12.15M-7.09M-5.90M-5.68M-4.95M-5.62M-6.41M-2.97M-5.41M
EBIT (Quarter)
-21.73M-13.69M-23.42M-12.83M-12.21M-7.45M-35.63M-9.87M-12.15M-7.09M-5.90M-5.68M-4.95M-5.62M-6.41M-2.97M-5.41M
Non-operating items
Non Operating Investment Income (Quarter)
-0.14M
Interest & Investment Income (Quarter)
Other Non Operating Income (Quarter)
Non Operating Income (Quarter)
-19.61M2.68M20.82M2.44M-0.40M7.87M-1.46M5.55M0.88M1.47M-1.53M4.07M1.23M-4.04M0.64M5.38M-5.11M
Net income details
EBT (Quarter)
-41.33M-11.01M8.41M-10.39M-12.61M0.42M-34.96M-4.32M-11.27M-5.63M-7.43M-1.61M-3.72M-9.66M-5.39M2.40M-10.52M
Tax Provisions (Quarter)
-3.64M-0.20M-0.38M0.13M-1.02M-0.08M0.05M0.02M
Profit After Tax (Quarter)
-40.05M-11.01M8.41M-27.26M-10.19M-12.23M0.29M-33.94M-4.23M-11.33M-1.95M1.35M-3.49M-3.74M57.42M-8.83M2.15M-10.52M
Income from Continuing Operations (Quarter)
-37.69M-11.01M8.41M-10.19M-12.23M0.29M-33.94M-4.23M-11.33M-5.63M-7.43M-1.61M-3.74M-9.66M-5.39M2.40M-10.52M
Consolidated Net Income (Quarter)
-37.69M-11.01M8.41M-10.19M-12.23M0.29M-33.94M-4.23M-11.33M3.67M-2.36M-1.88M-3.74M67.07M-3.44M-0.25M
Income towards Parent Company (Quarter)
-37.69M-11.01M8.41M-10.19M-12.23M0.29M-33.94M-4.23M-11.33M3.67M-2.36M-1.88M-3.74M67.07M-3.44M-0.25M
Net Income towards Common Stockholders (Quarter)
-37.69M-11.01M8.41M-10.19M-12.23M0.29M-33.94M-4.23M-11.33M3.67M-2.36M-1.88M-3.74M67.07M-3.44M-0.25M
Additional items
EPS (Basic) (Quarter)
-0.55-0.160.12-0.14-0.170.00-0.46-0.06-0.150.05-0.03-0.02-0.050.81-0.040.00
EPS (Diluted) (Quarter)
-0.55-0.160.11-0.14-0.170.00-0.46-0.06-0.150.05-0.03-0.02-0.050.81-0.040.00
Shares Outstanding (Quarter)
69.01M69.76M70.77M71.05M71.47M71.24M71.99M73.17M74.14M73.52M75.80M77.60M78.04M77.50M79.89M81.30M82.45M82.09M85.32M86.21M
Shares Outstanding (Diluted) (Quarter)
69.01M77.68M70.77M78.50M71.47M71.24M71.99M73.17M81.01M73.52M75.80M77.60M78.04M77.50M79.89M81.30M82.45M82.09M90.17M86.21M
Shares Outstanding (Entity) (Quarter)
70.10M70.67M70.85M71.40M71.51M71.66M72.50M73.17M74.21M75.13M77.15M77.93M78.31M79.42M80.97M81.70M86.05M86.70M86.52M88.47M
EBITDA (Quarter)
-21.73M-13.69M-23.42M-12.83M-12.21M-7.45M-35.63M-9.87M-12.15M-7.09M-5.90M-5.68M-4.95M-5.62M-6.41M-2.97M-5.41M
Interest Expenses (Quarter)
12.47M15.15M67.13M32.66M29.34M0.69M34.11M27.40M17.43M0.77M32.85M28.27M30.45M25.68M9.03M13.47M12.00M5.12M10.42M22.94M
Tax Rate (Quarter)
8.81%1.89%2.98%30.86%2.93%1.95%-0.46%-0.56%